1. 1574Safety Profile of HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 24 Analysis. (December 2014) Authors: Lalezari, Jacob; Latiff, Gulam H; Brinson, Cynthia; Echevarría, Juan; Treviño-Pérez, Sandra; Bogner, Johannes R; Stock, David; Joshi, Samit R; Hanna, George J; Lataillade, Max Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 540HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 24 Subgroup Analysis. (December 2014) Authors: Brinson, Cynthia; Lalezari, Jacob; Latiff, Gulam H; Thompson, Melanie; Echevarría, Juan; Treviño-Pérez, Sandra; Stock, David; Joshi, Samit R; Hanna, George J; Lataillade, Max Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C. Issue 2 (26th May 2015) Authors: Ahmad, Tariq; Yin, Philip; Saffitz, Jeffrey; Pockros, Paul J.; Lalezari, Jacob; Shiffman, Mitchell; Freilich, Bradley; Zamparo, Joann; Brown, Kyle; Dimitrova, Dessislava; Kumar, Monica; Manion, Doug; Heath‐Chiozzi, Margo; Wolf, Robert; Hughes, Eric; Muir, Andrew J.; Hernandez, Adrian F. Journal: Hepatology Issue: Volume 62:Issue 2(2015:Aug.) Page Start: 409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B. Issue 6 (16th November 2022) Authors: Feld, Jordan J; Lawitz, Eric; Nguyen, Tuan; Lalezari, Jacob; Hassanein, Tarek; Martin, Paul; Han, Steven-Huy; Dieterich, Douglas; Giard, Jeanne-Marie; De La Rosa, Guy; Ahmad, Alaa; Luo, Ed; Conery, Annie L; Adda, Nathalie Journal: Antiviral therapy Issue: Volume 27:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Faldaprevir combined with pegylated interferon alfa‐2a and ribavirin in treatment‐naïve patients with chronic genotype1 HCV: SILEN‐C1 trial12. Issue 6 (12th June 2013) Authors: Sulkowski, Mark S.; Asselah, Tarik; Lalezari, Jacob; Ferenci, Peter; Fainboim, Hugo; Leggett, Barbara; Bessone, Fernando; Mauss, Stefan; Heo, Jeong; Datsenko, Yakov; Stern, Jerry O.; Kukolj, George; Scherer, Joseph; Nehmiz, Gerhard; Steinmann, Gerhard G.; Böcher, Wulf O. Journal: Hepatology Issue: Volume 57:Issue 6(2013:Jun.) Page Start: 2143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Idx184 in Combination with Pegylated Interferon-α2A and Ribavirin for 2 Weeks in Treatment-Naive Patients with Chronic Hepatitis C. Issue 6 (August 2013) Authors: Lalezari, Jacob; Box, Terry; O'Riordan, William; Mehra, Purvi; Nguyen, Tuan; Poordad, Fred; DeJesus, Edwin; Kwo, Paul; Godofsky, Eliot; Lawrence, Shannon; Dubuc-Patrick, Gloria; Chen, Jie; McCarville, Joseph; Pietropaolo, Keith; Zhou, Xiao-Jian; Sullivan-Bólyai, John; Mayers, Douglas Journal: Antiviral therapy Issue: Volume 18:Issue 6(2013) Page Start: 755 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗